News LCT reports positive meetings with FDA and MedSafe - preparing for cell therapy trials Living Cell Technologies Limited (ASX:LCT) today reported it has held positive meetings with the US Food and Drug Administration (FDA) and New Zealand's MedSafe, regarding its NeurotrophinCell and DiabeCell products. Related Document |